JAMES CHENG-CHUNG WEI2026-10-162026-10-162026-05-01Pure ID: 15125970Pure UUID: 0db49e5e-33e4-4f10-bc79-4578c0d08cb910.1016/j.ajo.2026.01.020https://www.scopus.com/pages/publications/105030499663https://scholars.csmu.edu.tw/handle/123456789/32262Objective: To determine the risk of developing glaucoma following a diagnosis of idiopathic noninfectious uveitis and to stratify this risk by uveitis subtype, patient demographics, and corticosteroid use. Design: Retrospective cohort study using data from January 1, 2006, to December 31, 2024. Participants: Adult patients with noninfectious uveitis were identified within a multi-institutional US collaborative federated research network. Patients with systemic autoimmune diseases were excluded to isolate ocular inflammation risk. After 1:1 propensity score matching for age, sex, race, comorbidities, and medication use, two balanced cohorts of 16,910 patients each were established. Method: The exposure was a diagnosis of noninfectious uveitis. Patients were followed for the development of new glaucoma diagnoses, identified using ICD-10-CM codes. A sensitivity analysis using an ophthalmology encounters control group was performed to address potential surveillance bias. Main Outcome Measures: The primary outcome was the incidence of a new glaucoma diagnosis after the index date, identified by ICD-10-CM codes. Results: Patients with noninfectious uveitis had a nearly 10-fold increased risk of developing glaucoma compared to controls (hazard ratio [HR], 9.63; 95% CI, 7.75-11.95). This risk remained robust in the sensitivity analysis (HR, 7.11; 95% CI, 6.21-8.15). The risk was highest during the first follow-up year (HR, 33.78; 95% CI, 19.02-59.90), and was significant across most subtypes, including primary open-angle glaucoma (HR, 4.47; 95% CI, 3.50-5.69), primary angle-closure glaucoma (HR, 11.55; 95% CI, 5.60-23.82), and drug-induced glaucoma (HR, 51.29; 95% CI, 16.35-160.00). Among uveitis subtypes, panuveitis was associated with the greatest risk (HR, 50.49; 95% CI, 22.36-113.00). Stratified analyses showed a markedly elevated uveitis risk for glaucoma in the youngest age group (18-49 years: HR, 36.65; 95% CI, 18.14-74.00). Both systemic (HR, 10.19; 95% CI, 6.34-16.37) and ophthalmic (HR, 5.67; 95% CI, 3.88-8.30) corticosteroid use were associated with increased uveitis risk for glaucoma. Conclusions: Noninfectious uveitis is a significant risk factor for glaucoma, with the highest risk observed in younger adults, panuveitis patients, and during the first year after diagnosis. These findings underscore the need for a risk-stratified glaucoma surveillance to prevent irreversible vision loss.10enRisk of Glaucoma in Patients With Idiopathic Noninfectious UveitisA Multi-Institutional Real-World Retrospective Cohort Studyjournal article